Literature DB >> 15934300

Effect of angiotensin II on cord blood CD34+ cells expansion in vitro.

Cheng Peng1, Ping Zou, Yanping Ma, Zongbo Hu.   

Abstract

In order to investigate the influence of angiotensin II on hematopoietic system, CD34+ cells in cord blood were purified, and the effects of angiotensin II in combination with various cytokines on their growth and differentiation were studied by cell culture in vitro. It was found that angiotensin II in suspending medium could stimulate both BFU-E and CFU-GM expansion. The number of BFU-E and CFU-GM was increased with the increases of angiotensin II concentrations during a certain range. In addition, the expansion fold of CFU-GM was increased from 2.3 +/- 0.8 times to 7.8 +/- 2.3 times when angiotensin II was added in the presence of SCF+G-CSF+GM-CSF+IL3 cytokines mixture. Similarly, the expansion fold of BFU-E was increased from 3.1 +/- 1.8 times to 9. 2 +/- 2.3 times with angiotensin II in the presence of SCF+EPO+TPO+IL-3. In the semi-solid medium, angiotensin II could stimulate CFU-GM expansion but had no effect on the growth of BFU-E. In conclusion, angiotensin II had some stimulating effects on cord blood hematopoietic progenitors expansion in vitro in the presence of other cytokines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15934300     DOI: 10.1007/BF02831378

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  4 in total

1.  Long-term follow-up of renal transplant recipients treated with losartan for post-transplant erythrosis.

Authors:  D Ducloux; V Fournier; C Bresson-Vautrin; J M Chalopin
Journal:  Transpl Int       Date:  1998       Impact factor: 3.782

2.  Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice.

Authors:  J Cole; D Ertoy; H Lin; R L Sutliff; E Ezan; T T Guyene; M Capecchi; P Corvol; K E Bernstein
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

3.  Angiotensin II stimulates proliferation of normal early erythroid progenitors.

Authors:  M Mrug; T Stopka; B A Julian; J F Prchal; J T Prchal
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

4.  Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis.

Authors:  B A Julian; R R Brantley; C V Barker; T Stopka; R S Gaston; J J Curtis; J Y Lee; J T Prchal
Journal:  J Am Soc Nephrol       Date:  1998-06       Impact factor: 10.121

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.